ARCHIVES

FDA IND Approval Of New Cancer Drug Is First Based On Phase 1 Clinical Trials In Europe

This article is from The Cancer Letter archive.

Vol. 12 No. 47 | December 5, 1986

Download PDF Visit The Full Archive

Related Articles

Poverty Play Key Role In Excess Cancer Deaths Among Minorities, President’s Cancer Panel Hears

July 26, 1991

FDA Accepts Advisory Committee’s Recommendations On NDA, Labeling

October 26, 1979

In Brief: Armitage Appointed to NCAB; UT Board Approves New Clinical Building for MDACC

May 19, 2000

In Brief: MSK Opens Campaign On Colorectal Cancer Early Detection NIH Symposium Dedicates Cyclotron

August 28, 1987

Working Group Proposes “Equitable” Schema For Determining Cancer Center Core Grants

July 3, 2013

NCI Official Says He Hopes to “Put More Money” Into SPOREs.

April 14, 2006